Prostaglandin D2 synthase (also called β-trace) itself is a neuroprotective chaperone that inhibits Aβ aggregation (102, 103), and alterations to its expression may be a biomarker of several neurological disorders (104). This evidence concerns the gene PTGDS and nervous system disorder.